The hDPSC-products at 60-70% confluency were washed with 1 mL of phosphate buffered saline (PBS; Nacalai Tesque, Kyoto Japan) twice, and were cultured for 48 hours with 10 mL of a serum-free (SF) Dulbecco's Modified Eagle Medium without phenol red and antibiotics (DMEM (-); Thermo Fisher Scientific, Waltham, MA). The medium was collected as the CM into a 50 mL polystyrene tube (Corning, Corning, NY), and centrifuged for 3 minutes at 4 ºC and 440 × g. The supernatants were discarded into another 50 mL polystyrene tube (Corning), and were centrifuged for 3 minutes at 4 ºC and 17,400 × g. Total protein concentration in the CM was measured using a BCA protein assay (Thermo Fisher Scientific) according to the manufacturer's instruction, and was adjusted to 1 mg/mL with SF-DMEM (-).
Hepatogenic induction of hDPSC-products
The hDPSC-products (0.25 × 10 6 per dish) were seeded on human fibronectin-coated 100-mm culture dishes (Corning), and were cultured with 10 mL of a xeno-free medium MSC NutriStem® XF Medium (XFM; Biological Industries, Beit HaEmek, Israel) without antibiotics. After they reached confluency, the hDPSC-products were cultured in a sequential hepatogenic medium based on Iscove's Modified Dulbecco's Media (Thermo Fisher Scientific) . The hDPSC-products were preincubated with human epidermal growth factor (20 ng/mL; PeproTech, Rocky Hill, NJ) and human fibroblast growth factor 2 (10 ng/mL; FGF2; PeproTech) for 2 days. They were then stimulated with FGF2 (10 ng/mL; PeproTech), hepatocyte growth factor (20 ng/mL; HGF; PeproTech), and nicotinamide (5 mmol/L; Merck, Darmstadt, Germany) for 7 days, and were finally cultured with oncostatin M (20 ng/mL; PeproTech), dexamethasone (1 µmol/L; Merck), and ITS+ premix (50 mg/mL; Thermo Fisher Scientific) for 21 days.
The hDPSC-products were maintained at 37 ºC with 5% CO2 in a Forma TM CO2 incubator (Thermo Fisher Scientific). The medium was changed twice weekly. Expression of hepatocyte-specific genes was assessed by reverse transcription polymerase chain reaction (RT-PCR) assay to determine the hepatogenic differentiation Human peripheral blood mononuclear cells (PBMNCs) were obtained from peripheral blood from non-related donors (25-28 years old) to the pediatric donors for hDPSCs, and were separated by gradient centrifugation using a Ficoll-Paque PLUS density gradient reagent (GE Healthcare Life Sciences, Pittsburgh, PA). Intact PBMNCs (1 × 10 6 per well) were co-cultured with gamma-irradiated hDPSCs (10 × 10 3 per well) or gamma-irradiated PBMNCs (100 × 10 3 per well) in 96-well multiplates (Corning) with a complete medium. The hDPSCs and PBMNCs were treated at a dose of 30 Gy with an MBR-1520R-3 X-ray generator (Hitachi, Tokyo, Japan). The complete medium consisted of RPMI-1640 medium (Merck) with 10% heat-inactivated fetal bovine serum (FBS; Equitech-Bio, Kerrville, TX), L-glutamine (2 mmol/L; Nacalai Tesque), sodium pyruvate (1 mmol/L; Nacalai Tesque), and premixed antibiotics (100 U/ml penicillin and 100 µg/mL streptomycin; Nacalai Tesque). Some intact PBMNCs (1 × 10 6 per well) were pre-treated for 24 hours with the T-cell mitogen phytohemagglutinin (PHA; 5 µg/mL, Merck). Cell viability of the floating cells was assayed 3 days after the co-culture using a Cell Counting Kumamoto, Japan) . The results were measured on a Multiskan TM GO microplate spectrophotometer (Thermo Fisher Scientific).
ice-cold FCMB twice, and were analyzed on a FACSVerse TM flow cytometer (BD Bioscience, Franklin Lake, NJ) using the FACSuite TM software (BD Bioscience). The number (percentage) of positive cells was determined by comparison with the corresponding control cells stained with the corresponding isotype-matched antibody, in which a false-positive rate of less than 1% was accepted. The specific antibodies used for flow cytometric analysis are shown in Supplementary Table 4 .
Extraction and preparation of total RNA
Cellular and tissue samples were treated with a TRIzol ® reagent (Thermo Fisher Scientific). The RNA extracts were digested with a DNase I (Promega, Madison, WI), and were purified using an RNeasy ® Mini Kit (Qiagen). To check for genomic DNA contamination, the RNA extracts were directly reacted with a primer pair for human glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Sense, 5'-TGAAGGTCGGTGTCAACGGATTTGGC 3'; Antisense, 5'-CATGTAGGCCATGAGGTCCACCAC-3') and Quick Taq HS DyeMix (TOYOBO, Osaka, Japan) with a T-100 TM thermal cycler (Bio-Rad Laboratories). The amplification by PCR was as follows; initial activation step (95 ºC, 120 sec) and three-step cycling (95 ºC for 30 sec, 60 ºC for 30 sec, and 68 ºC for 60 sec; 30 cycles)
The concentration of human albumin, HGF, interleukin 6, monocyte chemoattractant protein-1, sialic acid-binding Ig-like lectin-9, mouse matrix metalloproteinase 2 (MMP2), mouse MMP9, mouse tissue inhibitors of metalloproteinase 1 (TIMP1), TIMP2, and transforming growth factor beta 1 in the CM of hDPSC cultures, mouse liver tissues, and mouse peripheral serum were analyzed by ELISA using commercially available kits according to the manufacturers' protocols. Biochemical assays for alanine aminotransferase, aspartate transferase, and total bilirubin in mouse serum were analyzed using commercially available kits according to the manufacturers' protocols.
Finally, the results from the immunological and biochemical tests were measured on a Multiscan TM GO microplate spectrophotometer (Thermo Fisher Scientific). The commercially available kits are listed in Supplementary Table 8 .
Preparation for histochemistry and immunohistochemistry
Mouse liver tissue samples were treated with 4% paraformaldehyde (Merck) in PBS (pH 7.4; Nacalai Tesque) for 18 hours. The samples were subsequently dehydrated in a graded ethanol bath and were cleaned in xylene. Finally, the samples were embedded in paraffin, and were cut into 6 mm-thick sections. The paraffin sections were dewaxed and were rehydrated for further histochemical and immunohistochemical studies.
Immunohistochemical analysis
Paraffin sections were incubated with 3.0 % H2O2 in ethanol for 30 min at room temperature to inhibit endogenous peroxidase. The sections were then treated with 10% normal mouse or rabbit serum in PBS for 60 min at room temperature. The sections were treated with primary antibodies overnight at 4 °C, followed by treatment with the EnVision+ System (Agilent Technologies, Santa Clara, CA) according to the manufacturer's instruction. Immunohistochemical negative controls were stained with non-immune isotype-matched IgG instead of the primary antibodies. Primary antibodies and isotype-matched antibodies used in immunohistochemical analysis are shown in Supplementary Table 9 . adipocyte-, chondrocyte-, and osteoblast-specific genes.
Names of genes Gene assay ID Numbers

ALP Hs01029144_m1
BGLAP Hs01587814_g1
COL10 Hs00166657_m1
LPL Hs00173425_m1
PPARG Hs0115513_m1
RUNX2 Hs00231692_m1
SOX9 Hs01001343_g1
Ribosomal RNA, 18S Hs99999901_s1
ALP, alkaline phosphatase gene; BGLAP, bone gamma-carboxyglutamate protein gene; Col10, collagen, type X gene; GAPDH, glyceraldehyde 3-phosphate dehydrogenase gene; LPL, lipoprotein lipase gene; PPARG, peroxisome proliferator activated receptor-gamma 2 gene; RUNX2, runt-related gene 2 gene; SOX9, SPY-box 9 gene.
hepatocyte-specific genes.
Names of genes Gene assay ID Numbers
AFP Hs00173490_m1
ALB Hs00910225_m1
ARG2 Hs00982833_m1
ASL Hs00902699_m1
ASS1 Hs01597989_g1
ATP7B Hs00163739_m1
CPS1 Hs00157048_m1
CYP3A7 Hs00426361_m1
FAH Hs00164611_m1
KRT18 Hs02827483_g1
NAGS Hs00400246_m1
OTC Hs00166892_m1
STC1 Hs00174970_m1
TF Hs01067777_m1
TTR Hs00174941_m1
Ribosomal RNA, 18S Hs99999901_s1 Supplementary Table 7 . TaqMan probe information for real-time RT-PCR Human Gene ID Number
STC1 Hs00174970_g1
Ribosomal RNA, 18S Hs99999901_s1 STC1, stanniocalcin 1.
Mouse
Gene
ID Number
Acta2 Mm00725412_s1 Col1a1 Mm00801666_g1 Mmp2 Mm00439498_m1
Mmp9
Mm00442991_m1.
Timp1 Mm01341361_m1
Timp2 Mm00441825_m1 Tgfb1 Mm01178820_m1
18S Mm03928990_g1
Acta2, actin, alpha 2, smooth muscle, aorta; Col1a1, collagen type I alpha 1 chain; Mmp2, matrix metalloprotein 2; Mmp9, matrix metalloprotein 9; TIMP1, TIMP metallopropeptidase inhibitor 1; TIMP2, TIMP metallopropeptidase inhibitor 2. ALT, alanine aminotransferase; AST: aspartic aminotransferase; HGF, hepatocyte growth factor; IL6, interleukin 6; MCP1, monocyte chemotactic protein 1; MMP2, matrix metalloproteinase 2; MMP9, matrix metalloproteinase 9; SIGLEC9, sialic acidbinding Ig-like lectin 9; TGFb1, Transforming growth factor beta; TIMP1, tissue inhibitor of matrix proteinases 1; TIMP1, tissue inhibitor of matrix proteinases 2. Supplementary Table 9 . Antibody information for immunohistochemistry. Supplementary Figure 5 . Anti-fibrotic effects of P10 hDPSC-transplantation in mouse CCl 4 -induced fibrotic liver. P10 hDPSC-products except for donor #3, #8, and #9 were intrasplenically transplanted into 4-week-CCl 4 -treated immunocompitent mice without immunosuppressant. (a) Expression of mouse matrix metalloprotease 2 (Mmp2), Mmp9, tissue inhibitor of metallopropeptidase 1 (Timp1), Timp2, and transforming growth factor beta 1 (Tgfb1) genes in mouse liver tissues was analyzed by quantitative reverse transcription polymerase chain reaction assay. The results were shown as the ratios to the expression of 18S ribosomal RNA (18S). (b) Expression of mouse MMP2, MMP9, TIMP1, TIMP2, and TGFB1 proteins in mouse liver tissues was analyzed by enzyme-linked immuno-sorbent assay. n = 5 for all groups. *P < 0.05, ***P < 0.005. The graph bars show means SEM (white columns) or means (black columns). N/A, not available; ns, not significant. 
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